Glucose tolerance before and after renal transplantation

被引:27
作者
Bergrem, Henrik Andreas [1 ]
Valderhaug, Tone Gretland [1 ,2 ]
Hartmann, Anders [1 ]
Bergrem, Harald [3 ]
Hjelmesaeth, Joran [4 ]
Jenssen, Trond [1 ,5 ]
机构
[1] Natl Hosp Norway, Oslo Univ Hosp, Dept Med, Oslo, Norway
[2] Natl Hosp Norway, Oslo Univ Hosp, Dept Thorac Surg, Oslo, Norway
[3] Stavanger Univ Hosp, Dept Med, Stavanger, Norway
[4] Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway
[5] Univ Tromso, Inst Clin Med, Tromso, Norway
关键词
hyperglycaemia; multiple imputation; oral glucose tolerance test; renal transplantation; urea; INSULIN-RESISTANCE; BLOOD-GLUCOSE; DIABETES-MELLITUS; CARBOHYDRATE-METABOLISM; KIDNEY-TRANSPLANTATION; CHRONIC-HEMODIALYSIS; PHOSPHATE LEVELS; SERUM-CALCIUM; UREMIA; SENSITIVITY;
D O I
10.1093/ndt/gfp566
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Methods. This is a retrospective cohort study involving 301 patients without pre-transplant DM. Measurements included a pre- and post-transplant oral glucose tolerance test (OGTT) as well as glomerular filtration rate (GFR), parathyroid hormone (PTH), phosphate, calcium and urea measured 10 weeks post-transplant. The risk of PHYG at 10 weeks post-transplant was analysed using multiple logistic regression. Results. Ninety-three patients (31%) had PHYG (two IFG, 52 IGT, 39 DM). Variables associated with PHYG included pre-transplant 2-h glycaemia [OR 1.26, 95% CI (1.09, 1.46)] and post-transplant urea levels [OR 1.14, 95% CI (1.02, 1.27)]. Older age, non-Caucasian ethnicity, previous transplants, >= 3 HLA class 1 mismatches and high prednisolone doses were likewise associated with an increased PHYG risk (all P < 0.05). Conclusions. Pre-transplant glycaemia and high post-transplant levels of urea were associated with a greater risk of PHYG. This seemed to be independent of GFR, PTH, phosphate, calcium and traditional risk factors such as age and glucocorticoid load.
引用
收藏
页码:985 / 992
页数:8
相关论文
共 46 条
[1]  
AMEND WJC, 1975, J LAB CLIN MED, V86, P435
[2]  
[Anonymous], 1999, Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation
[3]   EFFECTS OF UREMIC SERUM, UREA, CREATININE AND METHYLGUANIDINE ON GLUCOSE-METABOLISM [J].
BALESTRI, PL ;
BIAGINI, M ;
GIOVANNETTI, S ;
RINDI, P .
CLINICAL SCIENCE, 1972, 42 (04) :395-+
[4]   Imputations of missing values in practice: Results from imputations of serum cholesterol in 28 cohort studies [J].
Barzi, F ;
Woodward, M .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (01) :34-45
[5]   Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation [J].
Bayés, B ;
Lauzurica, R ;
Granada, ML ;
Serra, A ;
Bonet, L ;
Fontseré, N ;
Salinas, I ;
Romero, R .
TRANSPLANTATION, 2004, 78 (01) :26-30
[6]  
Brunner EJ, 2006, DIABETES CARE, V29, P26
[7]   Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: A novel glucocorticoid hierarchy [J].
Buttgereit, F ;
Brand, MD ;
Burmester, GR .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (02) :363-368
[8]   New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation [J].
Cosio, FG ;
Kudva, Y ;
van der Velde, M ;
Larson, TS ;
Textor, SC ;
Griffin, MD ;
Stegall, MD .
KIDNEY INTERNATIONAL, 2005, 67 (06) :2415-2421
[9]   Approved IFCC recommendation on reporting results for blood glucose (abbreviated) [J].
D'Orazio, P ;
Burnett, RW ;
Fogh-Andersen, N ;
Jacobs, E ;
Kuwa, K ;
Külpmann, WR ;
Larsson, L ;
Lewenstam, A ;
Maas, AHJ ;
Mager, G ;
Naskalski, JW ;
Okorodudu, AO .
CLINICAL CHEMISTRY, 2005, 51 (09) :1573-1576
[10]   New-onset diabetes after transplantation: 2003 International Consensus Guidelines [J].
Davidson, J ;
Wilkinson, A ;
Dantal, J ;
Dotta, F ;
Haller, H ;
Hernández, D ;
Kasiske, BL ;
Kiberd, B ;
Krentz, A ;
Legendre, C ;
Marchetti, P ;
Markell, M ;
van der Woude, FJ ;
Wheeler, DC .
TRANSPLANTATION, 2003, 75 (10) :SS3-SS24